Anna Mowry

Chief Financial Officer, Nautilus Biotechnology, Inc.

Companies

Nautilus Biotechnology, Inc.Chief financial officer Jun 9, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Nautilus Biotechnology, Inc. NAUT83,000 shares²$179.3K at $2.16May 29, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

May 29, 2025Bought 15,000 shares at $0.77 of Nautilus Biotechnology, Inc.²
Aug 19, 2022Bought 17,500 shares at $2.30 of Nautilus Biotechnology, Inc.³
Jun 27, 2022Bought 5,500 shares at $2.75 of Nautilus Biotechnology, Inc.⁴
Nov 24, 2021Bought 15,000 shares at $4.58 of Nautilus Biotechnology, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNautilus Biotechnology, Inc., Chief financial officer
2
SEC EDGARNautilus Biotechnology, Inc. shares after the filing of May 29, 2025
3
SEC EDGARForm 4 filed Aug 22, 2022
4
SEC EDGARForm 4 filed Jun 28, 2022
5
SEC EDGARForm 4 filed Nov 24, 2021